These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2474616)

  • 1. The human antibody response during natural bacteremic infection with gram-negative bacilli against lipopolysaccharide core determinants.
    Cross AS; Sidberry H; Sadoff JC
    J Infect Dis; 1989 Aug; 160(2):225-36. PubMed ID: 2474616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.
    Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ
    J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4.
    Schwartzer TA; Alcid DV; Numsuwan V; Gocke DJ
    J Infect Dis; 1989 Jan; 159(1):35-42. PubMed ID: 2462603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
    Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5.
    Baumgartner JD; Heumann D; Calandra T; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):769-72. PubMed ID: 2010630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to Escherichia coli J5 lipopolysaccharide and to Salmonella porin in patients with bacteremia.
    Brauner A; Källenius G; Wrangsell G; Wretlind B; Svenson SB
    Microb Pathog; 1986 Oct; 1(5):475-81. PubMed ID: 2854603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperimmunization of steers with J5 Escherichia coli bacterin: effects on isotype-specific serum antibody responses and cross reactivity with heterogeneous gram-negative bacteria.
    Chaiyotwittayakun A; Burton JL; Weber PS; Kizilkaya K; Cardoso FF; Erskine RJ
    J Dairy Sci; 2004 Oct; 87(10):3375-85. PubMed ID: 15377616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
    Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
    J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
    Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
    J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
    Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
    J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human vaccination with Escherichia coli J5 mutant induces cross-reactive bactericidal antibody against Neisseria gonorrhoeae lipooligosaccharide.
    Dale PA; McQuillen DP; Gulati S; Rice PA
    J Infect Dis; 1992 Aug; 166(2):316-25. PubMed ID: 1378871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting.
    de Jongh-Leuvenink J; Vreede RW; Marcelis JH; de Vos M; Verhoef J
    Infect Immun; 1985 Dec; 50(3):716-20. PubMed ID: 3905612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-lipopolysaccharide antibodies in gram-negative bacteremia.
    Baumgartner JD
    Behring Inst Mitt; 1991 Feb; (88):216-21. PubMed ID: 2049041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of swine hyperimmune serum against recombinant, common antigens of Gram-negative outer membrane bacteria.
    Rząsa A; Pietrasina O; Czerniecki M; Bajzert J; Stefaniak T
    Pol J Vet Sci; 2019 Mar; 22(1):117-125. PubMed ID: 30997780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
    Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
    J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.
    Hellman J; Zanzot EM; Loiselle PM; Amato SF; Black KM; Ge Y; Kurnick JT; Warren HS
    J Infect Dis; 1997 Nov; 176(5):1260-8. PubMed ID: 9359727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides.
    Pollack M; Raubitschek AA; Larrick JW
    J Clin Invest; 1987 May; 79(5):1421-30. PubMed ID: 2437155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.